MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss applicable
to common...
-$4,282,781
(59.44%↑ Y/Y)
Net loss
-$4,225,170
(59.76%↑ Y/Y)
Preferred stock dividend
requirements
$57,611
(0.00%↑ Y/Y)
Net loss before
income taxes
-$4,223,333
(58.66%↑ Y/Y)
Provision for income taxes
$1,837
(-99.36%↓ Y/Y)
Other income - tia
$1,477,730
(-0.34%↓ Y/Y)
Interest and other income
$295,124
(85.68%↑ Y/Y)
Unrealized gain (loss) on
debt and equity...
$192,172
(102.69%↑ Y/Y)
Syringes
$5,131,053
(-26.28%↓ Y/Y)
Easy Point Needles
$470,573
(-52.15%↓ Y/Y)
Blood Collection
Products
$340,462
(-0.98%↓ Y/Y)
Other Products
$6,237
(-18.83%↓ Y/Y)
Easy Point Needles
$435,888
(-55.68%↓ Y/Y)
Syringes
$419,362
(-93.97%↓ Y/Y)
Other Products
$600
(-92.19%↓ Y/Y)
Syringes
$251,858
(-96.38%↓ Y/Y)
Easy Point Needles
$86,744
(-91.18%↓ Y/Y)
Blood Collection
Products
$34,470
(-89.97%↓ Y/Y)
Other Products
$150
(-98.05%↓ Y/Y)
Loss from operations
-$6,167,918
(-31.88%↓ Y/Y)
Interest expense
$20,441
(-12.85%↓ Y/Y)
United States Sales
$5,948,325
(-19.97%↓ Y/Y)
North And South
America Sales Excluding...
$855,850
(54.63%↑ Y/Y)
Other International
Sales
$373,222
(20.64%↑ Y/Y)
Total operating
expenses
$5,329,510
(14.00%↑ Y/Y)
Gross profit (loss)
-$838,408
(-43772.74%↓ Y/Y)
Sales, net
$7,177,397
(-13.48%↓ Y/Y)
General and
administrative
$3,425,024
(18.85%↑ Y/Y)
Sales and marketing
$1,734,070
(8.26%↑ Y/Y)
Research and development
$170,416
(-10.87%↓ Y/Y)
Total cost of sales
$8,015,805
(-3.39%↓ Y/Y)
Product
$7,358,809
(-3.05%↓ Y/Y)
Royalty
$656,996
(-7.00%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
RETRACTABLE TECHNOLOGIES INC (RVP)
RETRACTABLE TECHNOLOGIES INC (RVP)